Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
MomentaVC
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2013 Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Silicozyme B.V. develops solutions for the downstream processing of biologics production.
Endo AxiomFounded 2023 • 51-200 employees
Endo Axiom — an enzyme-responsive oral platform for biologics. Lead programme: Type 1 diabetes. Next: autoimmune prevention and…
Neurolieve Biosciences is developing NLV-01, a first-in-class, non-opioid biologic designed to silence neuropathic pain and trigger…
Imbiologics51-200 employees
본문 바로가기 HOME 회사소개 기업소개 기업소개 IMBiologics Innovative Medicines based on ImmunoModulatory Biologics 당사는 2020년 8월 설립된 혁신 항체신약 개발 전문기업으로, 『최적 항체…
AntiverseSeries A $9.3M · 7 mo ago • Founded 2017
Antiverse combines generative AI and advanced antibody discovery to design functional, developable biologics for challenging drug targets.
PathoQuestSeries B $4.1M · 13 yr ago • 51-200 employees
PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for…

Overview

The CubiSens™ XT1 is a small smart sensor and revolutionary solution for monitoring the temperature of biologics at the product level.